ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS

<p>Data of evidence based medicine which confirm efficacy of acetylsalicylic acid (ACA) in cardiologic practice are presented. The special attention is given to generic drugs of ACA. Their application has increased essentially recently. Some of generics are comparable with original drugs on cl...

Full description

Bibliographic Details
Main Authors: N. A. Dmitrieva, S. N. Tolpygina
Format: Article
Language:English
Published: Столичная издательская компания 2016-01-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:http://www.rpcardio.ru/jour/article/view/738
_version_ 1797715523278995456
author N. A. Dmitrieva
S. N. Tolpygina
author_facet N. A. Dmitrieva
S. N. Tolpygina
author_sort N. A. Dmitrieva
collection DOAJ
description <p>Data of evidence based medicine which confirm efficacy of acetylsalicylic acid (ACA) in cardiologic practice are presented. The special attention is given to generic drugs of ACA. Their application has increased essentially recently. Some of generics are comparable with original drugs on clinical efficacy but have economic advantages.</p>
first_indexed 2024-03-12T08:08:00Z
format Article
id doaj.art-92e3ee87090049808ca28e93292736ec
institution Directory Open Access Journal
issn 1819-6446
2225-3653
language English
last_indexed 2024-03-12T08:08:00Z
publishDate 2016-01-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj.art-92e3ee87090049808ca28e93292736ec2023-09-02T19:20:33ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532016-01-0156555810.1234/1819-6446-2009-6-55-58737ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONSN. A. Dmitrieva0S. N. Tolpygina1Государственный научно-исследовательский центр профилактической медицины РосмедтехнологийГосударственный научно-исследовательский центр профилактической медицины Росмедтехнологий<p>Data of evidence based medicine which confirm efficacy of acetylsalicylic acid (ACA) in cardiologic practice are presented. The special attention is given to generic drugs of ACA. Their application has increased essentially recently. Some of generics are comparable with original drugs on clinical efficacy but have economic advantages.</p>http://www.rpcardio.ru/jour/article/view/738антиагрегантыацетилсалициловая кислотадженерический препарат
spellingShingle N. A. Dmitrieva
S. N. Tolpygina
ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS
Рациональная фармакотерапия в кардиологии
антиагреганты
ацетилсалициловая кислота
дженерический препарат
title ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS
title_full ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS
title_fullStr ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS
title_full_unstemmed ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS
title_short ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS
title_sort acetylsalicylic acid in low doses for secondary prevention of cardio vascular complications
topic антиагреганты
ацетилсалициловая кислота
дженерический препарат
url http://www.rpcardio.ru/jour/article/view/738
work_keys_str_mv AT nadmitrieva acetylsalicylicacidinlowdosesforsecondarypreventionofcardiovascularcomplications
AT sntolpygina acetylsalicylicacidinlowdosesforsecondarypreventionofcardiovascularcomplications